The cost-utility of intravenous magnesium sulfate for treating asthma exacerbations in children
Introduction Although evidence supports the use of intravenous magnesium sulfate (MS) in asthma exacerbations, MS continues to be considered a second‐line drug for managing pediatric asthma exacerbations. This study aimed to evaluate the cost‐utility of MS in asthma exacerbations. Methods We used a...
- Autores:
-
Buendia, Jefferson Antonio
Acuña-Cordero, Ranniery
Rodríguez-Martínez, Carlos E.
- Tipo de recurso:
- https://purl.org/coar/resource_type/c_6501
- Fecha de publicación:
- 2020
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/3933
- Acceso en línea:
- https://hdl.handle.net/20.500.12495/3933
https://doi.org/10.1002/ppul.25024
https://repositorio.unbosque.edu.co
- Palabra clave:
- Health care
Health economics
Public health
- Rights
- License
- Acceso abierto